These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 9399967)

  • 21. Agonist recognition site of the peripheral acetylcholine receptor ion channel complex differentiates the enantiomers of nicotine.
    Rozental R; Aracava Y; Scoble GT; Swanson KL; Wonnacott S; Albuquerque EX
    J Pharmacol Exp Ther; 1989 Nov; 251(2):395-404. PubMed ID: 2478693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation and inhibition of native neuronal alpha-bungarotoxin-sensitive nicotinic ACh receptors.
    Uteshev VV; Meyer EM; Papke RL
    Brain Res; 2002 Sep; 948(1-2):33-46. PubMed ID: 12383953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. alpha-Conotoxin ImI exhibits subtype-specific nicotinic acetylcholine receptor blockade: preferential inhibition of homomeric alpha 7 and alpha 9 receptors.
    Johnson DS; Martinez J; Elgoyhen AB; Heinemann SF; McIntosh JM
    Mol Pharmacol; 1995 Aug; 48(2):194-9. PubMed ID: 7651351
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuronal nicotinic receptor beta2 and beta4 subunits confer large differences in agonist binding affinity.
    Parker MJ; Beck A; Luetje CW
    Mol Pharmacol; 1998 Dec; 54(6):1132-9. PubMed ID: 9855644
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective alpha7-nicotinic agonists normalize inhibition of auditory response in DBA mice.
    Stevens KE; Kem WR; Mahnir VM; Freedman R
    Psychopharmacology (Berl); 1998 Apr; 136(4):320-7. PubMed ID: 9600576
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 5-I A-85380 and TC-2559 differentially activate heterologously expressed alpha4beta2 nicotinic receptors.
    Zwart R; Broad LM; Xi Q; Lee M; Moroni M; Bermudez I; Sher E
    Eur J Pharmacol; 2006 Jun; 539(1-2):10-7. PubMed ID: 16674940
    [TBL] [Abstract][Full Text] [Related]  

  • 27. C3-halogenation of cytisine generates potent and efficacious nicotinic receptor agonists.
    Abin-Carriquiry JA; Voutilainen MH; Barik J; Cassels BK; Iturriaga-Vásquez P; Bermudez I; Durand C; Dajas F; Wonnacott S
    Eur J Pharmacol; 2006 Apr; 536(1-2):1-11. PubMed ID: 16563372
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation and desensitization of nicotinic alpha7-type acetylcholine receptors by benzylidene anabaseines and nicotine.
    Papke RL; Kem WR; Soti F; López-Hernández GY; Horenstein NA
    J Pharmacol Exp Ther; 2009 May; 329(2):791-807. PubMed ID: 19223664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nicotinic pharmacology of anatoxin analogs. I. Side chain structure-activity relationships at peripheral agonist and noncompetitive antagonist sites.
    Swanson KL; Aronstam RS; Wonnacott S; Rapoport H; Albuquerque EX
    J Pharmacol Exp Ther; 1991 Oct; 259(1):377-86. PubMed ID: 1920124
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reversal of agonist selectivity by mutations of conserved amino acids in the binding site of nicotinic acetylcholine receptors.
    Horenstein NA; McCormack TJ; Stokes C; Ren K; Papke RL
    J Biol Chem; 2007 Feb; 282(8):5899-909. PubMed ID: 17189260
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nicotinic pharmacology of anatoxin analogs. II. Side chain structure-activity relationships at neuronal nicotinic ligand binding sites.
    Wonnacott S; Jackman S; Swanson KL; Rapoport H; Albuquerque EX
    J Pharmacol Exp Ther; 1991 Oct; 259(1):387-91. PubMed ID: 1920126
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A computational study of the binding of 3-(arylidene) anabaseines to two major brain nicotinic acetylcholine receptors and to the acetylcholine binding protein.
    Slavov SH; Radzvilovits M; LeFrancois S; Stoyanova-Slavova IB; Soti F; Kem WR; Katritzky AR
    Eur J Med Chem; 2010 Jun; 45(6):2433-46. PubMed ID: 20236734
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Two pharmacologically distinct components of nicotinic receptor-mediated rubidium efflux in mouse brain require the beta2 subunit.
    Marks MJ; Whiteaker P; Calcaterra J; Stitzel JA; Bullock AE; Grady SR; Picciotto MR; Changeux JP; Collins AC
    J Pharmacol Exp Ther; 1999 May; 289(2):1090-103. PubMed ID: 10215692
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological properties of nicotinic acetylcholine receptors expressed by guinea pig small intestinal myenteric neurons.
    Zhou X; Ren J; Brown E; Schneider D; Caraballo-Lopez Y; Galligan JJ
    J Pharmacol Exp Ther; 2002 Sep; 302(3):889-97. PubMed ID: 12183644
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Pharmacological Comparison of Two Isomeric Nicotinic Receptor Agonists: The Marine Toxin Isoanatabine and the Tobacco Alkaloid Anatabine.
    Xing H; Keshwah S; Rouchaud A; Kem WR
    Mar Drugs; 2020 Feb; 18(2):. PubMed ID: 32053997
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro binding characteristics of [3H]AZ11637326, a novel alpha7-selective neuronal nicotinic receptor agonist radioligand.
    Gordon JC; Phillips E; Gurley DA; Heys JR; Lazor LA; Barthlow HG; Mallamaci MA; Keith RA
    Eur J Pharmacol; 2010 Oct; 645(1-3):63-9. PubMed ID: 20674564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. alpha7 receptor-selective agonists and modes of alpha7 receptor activation.
    Papke RL; Meyer E; Nutter T; Uteshev VV
    Eur J Pharmacol; 2000 Mar; 393(1-3):179-95. PubMed ID: 10771012
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Actions of piperidine alkaloid teratogens at fetal nicotinic acetylcholine receptors.
    Green BT; Lee ST; Panter KE; Welch KD; Cook D; Pfister JA; Kem WR
    Neurotoxicol Teratol; 2010; 32(3):383-90. PubMed ID: 20116429
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovery of novel α7 nicotinic acetylcholine receptor ligands via pharmacophoric and docking studies of benzylidene anabaseine analogs.
    Kombo DC; Mazurov AA; Chewning J; Hammond PS; Tallapragada K; Hauser TA; Speake J; Yohannes D; Caldwell WS
    Bioorg Med Chem Lett; 2012 Jan; 22(2):1179-86. PubMed ID: 22177081
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro screening strategies for nicotinic receptor ligands.
    Dunlop J; Roncarati R; Jow B; Bothmann H; Lock T; Kowal D; Bowlby M; Terstappen GC
    Biochem Pharmacol; 2007 Oct; 74(8):1172-81. PubMed ID: 17706607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.